Breast Cancer Screening Market Increasing Prevalence of Breast Cancer and Rising Demand for Early Stage Disease Diagnosis in Developed and Emerging Economies

According to Precision Business Insights (PBI) latest report, the breast cancer screening market was valued at USD 2,487.3 million in 2023, growing at a 6.8% CAGR during the forecast period 2024 to 2030. The key drivers for the growth of the global breast cancer screening market include improved healthcare infrastructure, advancements in breast cancer screening technologies, the rising prevalence of breast cancers in aging women, and the promotion of early cancer detection.

View Full Report: https://www.precisionbusinessinsights.com/market-reports/breast-cancer-screening-market

THE BREAST CANCER SCREENING MARKET DETAILED SEGMENTATION:
Based on the Component, the market is segmented into the following:
• Reagents and Kits
• Instruments
• Software and Services

Based on the Technology, the market is segmented into the following:
• Imaging
• Biopsy
• Genomic Tests
• Blood Tests
• Mammography
• Others

Based on the Application, the market is segmented into the following:
• Screening
• Diagnostic and Predictive
• Prognostic
• Research

Based on the End-User, the market is segmented into the following:
• Hospitals and Clinics
• Diagnostic Centres
• Academic and Research Institutes
• Others

Request Sample: https://www.precisionbusinessinsights.com/request-sample/?product_id=57254

Mammography is expected to Dominate the Breast Cancer Screening market:
Based on the technology, the global breast screening market is segmented into imaging, biopsy, genomic tests, blood tests, mammography, and others. Among all of these mammography is anticipated to account large revenue share in the forecast period. A mammogram is an X-ray picture of the breast. Mammograms can be utilized to check for breast cancer in women who have no signs or symptoms of the disease. Furthermore, the imaging test is the most frequently used screening test for breast cancer, which is deliberated as the most reliable. Mammograms are the most extensively used tests to screen for breast cancer. Since mammography is the standard technique for screening breast cancer, governments and other healthcare organizations worldwide are taking inventiveness to develop access for women between 55 and 80. For instance, as demonstrated by the National Cancer Institute (NCI), reported in October 2021, The NCI is investing on the tomosynthesis mammographic imaging screening trial (TMIST), a large-scale randomized breast screening trial that will relate the number of advanced cancers detected in women screened for nearly five years with 3-D mammography to the number noticed in women screened with 2-D mammography.

Based on the geography the market is segmented into the following:
• North America
• Europe
• The Asia Pacific
• Latin America
• MEA

The North America market is expected to increase in the Breast Cancer Screening market over the forecast period. The North America market is expanding as a result, the increasing prevalence of tumors especially breast cancers, and uterine cancers in aging women in the developed economies, assembled with an effort to improve healthcare infrastructure and awareness, has opened up proficient growth opportunities. Moreover, Governments in the developed economies also implement favorable policies. For instance, as per Canadian Medical Association Journal, an assessed 28,800 new breast cancer cases were anticipated to occur in Canada in 2022, accounting for 27% of total new cancer diagnoses in women in Canada in 2022, which in turn is anticipated to drive the breast cancer screening market in the forecast period (2024-2030).

Request Methodology: https://www.precisionbusinessinsights.com/request-methodology/?product_id=57254

Strategic New Product Launches, Mergers, Acquisitions, and Concurrence are the key tactics adopted by market players:
In the recent research the Breast Cancer Screening market further divulge that the key players are intensively adopting strategies such as the launch of newer devices, and long-term alliances to improve market revenue share and gain significant geographic presence across the region. For instance, In June 2022, Biomerica, Inc. passed in a broad-spectrum merchandise supplier agreement with Walmart. The Aware Breast Self-Exam device will be flogged in Walmart's retail system.

The key market players in the breast cancer screening market are General Electric Company, Siemens Healthineers AG, BD, Danaher, Hoffmann-La Roche Ltd., Hologic Inc., Koninklijke Philips N.V., Myriad Genetics, Oncocyte Corporation, QIAGEN, Syantra, Inc., Thermo Fisher Scientific Inc.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to delivering more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.